[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.144.194.161. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
February 4, 2004

Ebola Vaccines Tested in Humans, Monkeys

JAMA. 2004;291(5):549-550. doi:10.1001/jama.291.5.549

While the World Health Organization is helping to contain another outbreak of Ebola hemorrhagic fever in West Africa—the fifth in two years—two vaccine candidates are raising hope that the world's deadliest virus will soon be tamed .

The first, a DNA "primer" containing DNA from the three known strains of Ebola virus, was injected into volunteers starting in November 2002. Its creators, mainly at the National Institutes of Health (NIH) envision it as stage one of a "prime-boost" strategy, with the booster using an adenovirus to smuggle additional Ebola virus DNA into antigen-presenting immune cells.

First Page Preview View Large
First page PDF preview
First page PDF preview
×